Thus, Theramir's technologies have the potential to revolutionize the precision oncology field by creating new knowledge on the pathology of the disease and enabling the customization and personalization of cancer treatment. With a focus on the biopharma, biotechnology, and pharmaceutical industries, Theramir presents an exciting opportunity for investors looking to support groundbreaking advancements in cancer therapeutics and diagnostics. As of now, there is no public information available regarding the last investment and last investment investors.
Theramir Ltd
Developing novel microRNA based therapeutics and companion diagnostics for patients and healthcare providers
Founded 2016
Cyprus
8 employees
Biopharma, Biotechnology +1
Cyprus
8 employees
Biopharma, Biotechnology +1
General Information
Get notified when Theramir Ltd moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Theramir Ltd
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Cyprus Market
Biopharma
About Theramir Ltd
Taxonomy: microRNA, therapeutics, companion diagnostics, oncology, precision medicine, cancer treatment, personalized medicine, targeted therapy, oncoproteins, gene regulation, cancer research, biomarkers, pathology, precision oncology
No funding data available for Theramir Ltd yet.
Get notified when Theramir Ltd raises fundingTheramir Ltd Alternatives & Competitors
Theramir Ltd vs
Fore Biotherapeutics
United States
A precision oncology company rooted in science and innovation, developing cancer therapies guided by...
Series D
46 employees
Biotechnology, Health Care
Theramir Ltd vs
bridge7 Oncology
Canada
Bridge7 uses AI to scale clinical expertise to improve the efficiency, consistency and quality of de...
Seed
4 employees
AI, Health Care
Theramir Ltd vs
Cvergenx
United States
An innovative leader in cancer molecular diagnostics, delivering personalized radiation therapy to e...
Seed
2 employees
Biotechnology, Health Care
FAQ About Theramir Ltd
Developing novel microRNA based therapeutics and companion diagnostics for patients and healthcare providers
Theramir Ltd was founded in 2016.
Theramir Ltd is headquartered in Cyprus.
Theramir Ltd operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Theramir Ltd has approximately 8 employees.
Top alternatives and competitors to Theramir Ltd include Fore Biotherapeutics, bridge7 Oncology, Cvergenx, Probmet Therapeutics, Aster Insights. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Theramir Ltd and Fore Biotherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Theramir Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.